70 related articles for article (PubMed ID: 19789041)
1. Completion Pancreatectomy. Indications and Outcomes: A Systematic Review.
Vouros D; Bramis K; Alexakis N; Kotsarinis V; Antonakis P; Memos N; Konstadoulakis M; Toutouzas K
Am Surg; 2023 Dec; 89(12):6134-6146. PubMed ID: 37295804
[TBL] [Abstract][Full Text] [Related]
2. Segmental Duodenal Resections: Toward Defining Indications, Complexity, and Coding.
Patel DD; Abdulkarim AB; Behrman SW
J Gastrointest Surg; 2023 Nov; 27(11):2373-2379. PubMed ID: 37749459
[TBL] [Abstract][Full Text] [Related]
3. ASO Author Reflections: Evaluating the Safety of Completion Total Pancreatectomy Compared with Initial Total Pancreatectomy.
Kanemitsu E; Masui T; Hatano E
Ann Surg Oncol; 2023 Jul; 30(7):4407-4408. PubMed ID: 36933083
[No Abstract] [Full Text] [Related]
4. Response to: Comment on: Pancreatectomy With Islet-Autotransplantation as Alternative for Pancreato-Duodenectomy in Patients With a High-Risk for Postoperative Pancreatic Fistula: The Jury Is Still Out.
Balzano G; Zerbi A; Scavini M; Piemonti L
Ann Surg Open; 2023 Mar; 4(1):e261. PubMed ID: 37600887
[No Abstract] [Full Text] [Related]
5. Pancreatic Neuroendocrine Tumors in MEN1 Patients: Difference in Post-Operative Complications and Tumor Progression between Major and Minimal Pancreatic Surgeries.
Tonelli F; Marini F; Giusti F; Iantomasi T; Giudici F; Brandi ML
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894286
[TBL] [Abstract][Full Text] [Related]
6. Pancreaticoduodenectomy Is the Best Surgical Procedure for Zollinger-Ellison Syndrome Associated with Multiple Endocrine Neoplasia Type 1.
Kong W; Albers MB; Manoharan J; Goebel JN; Kann PH; Jesinghaus M; Bartsch DK
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454834
[TBL] [Abstract][Full Text] [Related]
7. Intertumor heterogeneity in 60 pancreatic neuroendocrine tumors associated with multiple endocrine neoplasia type 1.
Selberherr A; Koperek O; Riss P; Scheuba C; Niederle MB; Kaderli R; Perren A; Niederle B
Orphanet J Rare Dis; 2019 Feb; 14(1):54. PubMed ID: 30795813
[TBL] [Abstract][Full Text] [Related]
8. Results of Duodenopancreatic Reoperations in Multiple Endocrine Neoplasia Type 1.
Albers MB; Manoharan J; Bollmann C; Chlosta MP; Holzer K; Bartsch DK
World J Surg; 2019 Feb; 43(2):552-558. PubMed ID: 30288555
[TBL] [Abstract][Full Text] [Related]
9. Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small ≤2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study: Association Francophone de Chirurgie Endocrinienne & Groupe d'Etude des Tumeurs Endocrines.
Triponez F; Sadowski SM; Pattou F; Cardot-Bauters C; Mirallié E; Le Bras M; Sebag F; Niccoli P; Deguelte S; Cadiot G; Poncet G; Lifante JC; Borson-Chazot F; Chaffanjon P; Chabre O; Menegaux F; Baudin E; Ruszniewski P; Du Boullay H; Goudet P
Ann Surg; 2018 Jul; 268(1):158-164. PubMed ID: 28263205
[TBL] [Abstract][Full Text] [Related]
10. Surgical management of pancreatico-duodenal tumors in multiple endocrine neoplasia syndrome type 1.
Akerström G; Stålberg P; Hellman P
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):173-8. PubMed ID: 22584725
[TBL] [Abstract][Full Text] [Related]
11. [Surgery for neuroendocrine tumors of the gastroenteropancreatic system (GEP-NET)].
Goretzki PE; Starke A; Akca A; Lammers BJ
Internist (Berl); 2012 Feb; 53(2):152-60. PubMed ID: 22290318
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of surgery for pancreatic neuroendocrine neoplasms in patients with MEN1.
Lopez CL; Waldmann J; Fendrich V; Langer P; Kann PH; Bartsch DK
Langenbecks Arch Surg; 2011 Dec; 396(8):1187-96. PubMed ID: 21805182
[TBL] [Abstract][Full Text] [Related]
13. [Neuroendocrine tumors of the duodenum and pancreas. Surgical strategy].
Fischer L; Mehrabi A; Büchler MW
Chirurg; 2011 Jul; 82(7):583-90. PubMed ID: 21656305
[TBL] [Abstract][Full Text] [Related]
14. Care for patients with multiple endocrine neoplasia type 1: the current evidence base.
Pieterman CR; Vriens MR; Dreijerink KM; van der Luijt RB; Valk GD
Fam Cancer; 2011 Mar; 10(1):157-71. PubMed ID: 21061174
[TBL] [Abstract][Full Text] [Related]
15. Completion pancreatectomy and duodenectomy for recurrent MEN-1 pancreaticoduodenal endocrine neoplasms.
Gauger PG; Doherty GM; Broome JT; Miller BS; Thompson NW
Surgery; 2009 Oct; 146(4):801-6; discussion 807-8. PubMed ID: 19789041
[TBL] [Abstract][Full Text] [Related]
16. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
17. [Surgical therapy of gastrinoma with associated Zollinger-Ellison syndrome].
Schröder W; Hölscher AH; Beckurts KT; Schusdziarra V; Höfler H; Siewert JR
Z Gastroenterol; 1996 Aug; 34(8):465-72. PubMed ID: 8967120
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of a selective surgical approach to management of Zollinger-Ellison syndrome in patients with MEN-1.
Mortellaro VE; Hochwald SN; McGuigan JE; Copeland EM; Vogel SB; Grobmyer SR
Am Surg; 2009 Aug; 75(8):730-3. PubMed ID: 19725300
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in the localization and surgical management of duodenal gastrinomas.
Lawton GP; Modlin IM
Curr Opin Gen Surg; 1994; ():131-7. PubMed ID: 7583948
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
